Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cavalli

Showing results (271-280 of 350) with videos related to

Pageof 35
Sort By:
Cancer|October 15, 1984
Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neckM Rozencweig, P Dodion, U Bruntsch, et al.
Blood|January 1, 1980
Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studiesM Coleman, R T Silver, T F Pajak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Phase I study of the novel distamycin derivative tallimustine (FCE 24517)C Sessa, O Pagani, M G Zurlo, et al.
British Journal of Cancer|October 18, 2007
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patientsM Frattini, P Saletti, E Romagnani, et al.
Cancer Treatment Reports|September 1, 1984
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideR A Joss, P Alberto, J P Obrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82H J Senn, R Maibach, M Castiglione, et al.
Leukemia|May 10, 2000
BCL10 gene mutations rarely occur in lymphoid malignanciesS Luminari, D Intini, L Baldini, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
Phase I-II study of escalating doses of amifostine combined with high-dose cyclophosphamideM Ghielmini, S Van der Bosch, M Bosshard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivativeO Pagani, M Zucchetti, C Sessa, et al.
European Journal of Cancer|July 1, 1979
Dianhydrogalactitol (NSC-132313): phase II study in solid tumorsR de Jager, A Brugarolas, H Hansen, et al.
Pageof 35

Showing results (271-280 of 350) with videos related to

Sort By:
Pageof 35
Cancer|October 15, 1984
Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neckM Rozencweig, P Dodion, U Bruntsch, et al.
Blood|January 1, 1980
Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studiesM Coleman, R T Silver, T F Pajak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Phase I study of the novel distamycin derivative tallimustine (FCE 24517)C Sessa, O Pagani, M G Zurlo, et al.
British Journal of Cancer|October 18, 2007
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patientsM Frattini, P Saletti, E Romagnani, et al.
Cancer Treatment Reports|September 1, 1984
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideR A Joss, P Alberto, J P Obrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82H J Senn, R Maibach, M Castiglione, et al.
Leukemia|May 10, 2000
BCL10 gene mutations rarely occur in lymphoid malignanciesS Luminari, D Intini, L Baldini, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
Phase I-II study of escalating doses of amifostine combined with high-dose cyclophosphamideM Ghielmini, S Van der Bosch, M Bosshard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivativeO Pagani, M Zucchetti, C Sessa, et al.
European Journal of Cancer|July 1, 1979
Dianhydrogalactitol (NSC-132313): phase II study in solid tumorsR de Jager, A Brugarolas, H Hansen, et al.
Pageof 35